Ensayos clinicos

536 ensayos encontrados

ReclutandoFase 3ClinicalTrials.gov

18-month Double-blind, Randomized, Placebo-controlled, Multicenter, Phase 3 Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease and in Late-infantile and Juvenile-onset Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

INTERVENTIONALInicio: 30 de jun de 2025ID: NCT07082725

CompletadoFase 3ClinicalTrials.gov

A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder

INTERVENTIONALInicio: 1 de mar de 2009ID: NCT00849693

ReclutandoClinicalTrials.gov

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

OBSERVATIONALInicio: 1 de jul de 2012ID: NCT01574053

CompletadoClinicalTrials.gov

Clinical and Immunologic Impact of SARS-CoV-2 in Hospitalized Pregnant Women and Neonates in Argentina

OBSERVATIONALInicio: 10 de jul de 2020ID: NCT04362956

CompletadoFase 4ClinicalTrials.gov

A Phase IV Study to Evaluate Decreased Dose Frequency in Patients With Systemic Juvenile Arthritis (SJIA) Who Experience Laboratory Abnormalities During Treatment With Tocilizumab

INTERVENTIONALInicio: 10 de jun de 2013ID: NCT01734382

CompletadoFase 3ClinicalTrials.gov

A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319

INTERVENTIONALInicio: 2 de may de 2019ID: NCT03785405

Activo, no reclutaClinicalTrials.gov

Real World Utilization of Upadacitinib in Adult and Adolescent Patients Living With Moderate to Severe Atopic Dermatitis (AD-VISE)

OBSERVATIONALInicio: 17 de nov de 2021ID: NCT05081557

CompletadoFase 1ClinicalTrials.gov

Phase 1 Study on the Use of Racotumomab Anti-idiotype Antibody in Patients With Pediatric Malignancies That Express N-glycolylated Gangliosides and Are Resistant to Conventional Treatment.

INTERVENTIONALInicio: 1 de feb de 2011ID: NCT01598454

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Multinational, Open-Label Extension Study to Evaluate the Long-Term Safety of CC-93538 in Adult and Adolescent Subjects With Eosinophilic Esophagitis

INTERVENTIONALInicio: 14 de sept de 2021ID: NCT04991935

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 Years of Age)

INTERVENTIONALInicio: 29 de ene de 2026ID: NCT07288567

CompletadoFase 3ClinicalTrials.gov

A 12-month, Multicenter, Open Label, Randomized, Controlled Study to Evaluate the Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced CNI, and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients With a 24-month Additional Safety Follow-up.

INTERVENTIONALInicio: 17 de ago de 2012ID: NCT01544491

CompletadoFase 1ClinicalTrials.gov

A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Polyarticular Juvenile Idiopathic Arthritis

INTERVENTIONALInicio: 1 de jul de 2013ID: NCT01904279

CompletadoFase 3ClinicalTrials.gov

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 mcg and 5 mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma

INTERVENTIONALInicio: 1 de ene de 2011ID: NCT01277523

TerminadoFase 2ClinicalTrials.gov

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Clinical Outcomes, Antiviral Activity, Safety, Tolerability, Pharmacokinetics, and Pharmacokinetics/Pharmacodynamics of JNJ-53718678 in Adult and Adolescent Hematopoietic Stem Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

INTERVENTIONALInicio: 26 de dic de 2019ID: NCT04056611

Activo, no reclutaFase 3ClinicalTrials.gov

LIBELULA™: An Open-label, Single-arm, Multi-center, Phase 3 Study on the Efficacy, Safety, and Pharmacokinetics of Debio 4326, a Triptorelin 12-month Formulation, in Pediatric Participants With Central Precocious Puberty

INTERVENTIONALInicio: 31 de jul de 2024ID: NCT06129539

ReclutandoFase 3ClinicalTrials.gov

Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

INTERVENTIONALInicio: 5 de abr de 2023ID: NCT05692180

CompletadoFase 3ClinicalTrials.gov

A Double Blind, Randomised, Placebo-controlled Trial to Evaluate the Dose-exposure and Safety of Nintedanib Per os on Top of Standard of Care for 24 Weeks, Followed by Open Label Treatment With Nintedanib of Variable Duration, in Children and Adolescents (6 to 17 Year-old) With Clinically Significant Fibrosing Interstitial Lung Disease

INTERVENTIONALInicio: 3 de dic de 2019ID: NCT04093024

Aun no reclutaClinicalTrials.gov

Analysis of Variability in the Management of Respiratory Infections in Hospitalized Patients Under 2 Years of Age Using Propensity Score Matching in Pediatric Inpatient Units"

OBSERVATIONALInicio: 1 de oct de 2025ID: NCT07202585

Activo, no reclutaClinicalTrials.gov

Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients Whose Disease is Not Adequately Controlled With Topical Prescription Therapies or When Those Therapies Are Not Medically Advisable

OBSERVATIONALInicio: 5 de abr de 2019ID: NCT03849716

CompletadoFase 2ClinicalTrials.gov

A Randomised, Double-blind, Placebo Controlled, Parallel Group, Dose Ranging Study Evaluating the Efficacy and Safety of GW642444M Administered Once Daily Compared With Placebo for 28 Days in Adolescent and Adult Subjects With Persistent Asthma

INTERVENTIONALInicio: 1 de dic de 2007ID: NCT00600171